---
title: "Merck & Co. Inc. Stock Outperforms Competitors On Strong Trading Day"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295842935.md"
description: "Merck & Co. (MRK) shares rose 1.98% to $135.55, hitting a new 52-week high and outperforming competitors like Johnson & Johnson, Pfizer, and Eli Lilly on August 13, 2026. This marked the second consecutive day of gains for Merck, contributing to a positive trading session where the S&P 500 and Dow Jones also advanced."
datetime: "2026-08-13T20:33:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295842935.md)
  - [en](https://longbridge.com/en/news/295842935.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295842935.md)
---

# Merck & Co. Inc. Stock Outperforms Competitors On Strong Trading Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Merck & Co. Inc. (MRK) advanced 1.98% to $135.55 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.65% to 7,798.99 and the Dow Jones Industrial Average rising 0.13% to 53,839.99.

This was the stock's second consecutive day of gains.

Merck & Co. Inc. hit a new 52-week high, surpassing its previous peak of $135.05, which the company reached on July 28th.

The stock outperformed some of its competitors Thursday, as Johnson & Johnson (JNJ) rose 0.47% to $262.08, Pfizer Inc. (PFE) rose 1.86% to $26.80, and Eli Lilly & Co. (LLY) fell 0.92% to $1,209.00.

Trading volume (8.9 M) remained 1.5 million below its 50-day average volume of 10.3 M.

Data source: Dow Jones Market Data, FactSet. Data compiled August 13, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

08-13-26 1633ET

### Related Stocks

- [MRK.US](https://longbridge.com/en/quote/MRK.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [JNJ.US](https://longbridge.com/en/quote/JNJ.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [LLY.US](https://longbridge.com/en/quote/LLY.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [BioInvent says FDA grants Fast Track designation for BI-1808 plus Keytruda in ovarian cancer](https://longbridge.com/en/news/295205178.md)
- [Merck says FDA accepts sBLA to expand ENFLONSIA RSV prevention to high-risk children under 2 for second season](https://longbridge.com/en/news/295093390.md)
- [Do Wall Street Analysts Like Public Service Enterprise Stock?](https://longbridge.com/en/news/295658899.md)
- [FACTBOX-Global drugmakers invest billions to boost US presence](https://longbridge.com/en/news/295412790.md)
- [Merck charts long-term path for first PCSK9 pill](https://longbridge.com/en/news/294860610.md)